Literature DB >> 23713595

Impact of co-morbidities on self-rated health in self-reported COPD: an analysis of NHANES 2001-2008.

Nirupama Putcha1, Milo A Puhan, Nadia N Hansel, M Brad Drummond, Cynthia M Boyd.   

Abstract

Chronic Obstructive Pulmonary Disease (COPD) coexists with co-morbidities. While co-morbidity has been associated with poorer health status, it is unclear which conditions have the greatest impact on self-rated health. We sought to determine which, and how much, specific co-morbid conditions impact on self-rated health in current and former smokers with self-reported COPD. Using the 2001-2008 National Health and Nutrition Examination Survey we characterized the association between thirteen co-morbidities and health status among individuals self-reporting COPD. Adjusted odds ratios (ORs) were generated using ordinal logistic regression. Additionally we evaluated the impact of increasing number of co-morbidities with self-rated health. Eight illnesses had significant associations with worse self-rated health, however after mutually adjusting for these conditions, congestive heart failure (OR 3.07, 95% CI 1.69-5.58), arthritis (OR 1.69, 95% CI 1.13-2.52), diabetes (OR 1.63, 95% CI 1.01-2.64), and incontinence/prostate disease (OR 1.63, 95% CI 1.01-2.62) remained independent predictors of self-rated health. Each increase in co-morbidities was associated with a 43% higher chance of worse self-rated health (95% CI 1.27-1.62). Individuals with COPD have a substantial burden of co-morbidity, which is associated with worse self-rated health. CHF, arthritis, diabetes and incontinence/prostate disease have the most impact on self-rated health. Targeting these co-morbidities in COPD may result in improved self-rated health.

Entities:  

Mesh:

Year:  2013        PMID: 23713595      PMCID: PMC4459792          DOI: 10.3109/15412555.2012.744963

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  30 in total

1.  Interpreting COPD prevalence estimates: what is the true burden of disease?

Authors:  R J Halbert; Sharon Isonaka; Dorothy George; Ahmar Iqbal
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

2.  Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.

Authors:  Johanna R Feary; Laura C Rodrigues; Christopher J Smith; Richard B Hubbard; Jack E Gibson
Journal:  Thorax       Date:  2010-09-25       Impact factor: 9.139

3.  Mortality after hospitalization for COPD.

Authors:  Pedro Almagro; Esther Calbo; Anna Ochoa de Echagüen; Bienvenido Barreiro; Salvador Quintana; José L Heredia; Javier Garau
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

4.  Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses.

Authors:  R Graham Barr; Julie Herbstman; Frank E Speizer; Carlos A Camargo
Journal:  Am J Epidemiol       Date:  2002-05-15       Impact factor: 4.897

5.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

6.  The influence of COPD on health-related quality of life independent of the influence of comorbidity.

Authors:  Jeannette G van Manen; Patrick J E Bindels; Friedo W Dekker; Bernardus J A M Bottema; Jaring S van der Zee; C Joris Ijzermans; Egbert Schadé
Journal:  J Clin Epidemiol       Date:  2003-12       Impact factor: 6.437

7.  The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease.

Authors:  Laura C M Boudestein; Frans H Rutten; Maarten J Cramer; Jan Willem J Lammers; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2009-11-03       Impact factor: 15.534

8.  Validation of self-reported chronic obstructive pulmonary disease among patients in the ED.

Authors:  Michael S Radeos; Rita K Cydulka; Brian H Rowe; R Graham Barr; Sunday Clark; Carlos A Camargo
Journal:  Am J Emerg Med       Date:  2009-02       Impact factor: 2.469

9.  Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004.

Authors:  Neal L Benowitz; John T Bernert; Ralph S Caraballo; David B Holiday; Jiantong Wang
Journal:  Am J Epidemiol       Date:  2008-11-19       Impact factor: 4.897

10.  Public health surveillance for mental health.

Authors:  Elsie J Freeman; Lisa J Colpe; Tara W Strine; Satvinder Dhingra; Lisa C McGuire; Laurie D Elam-Evans; Geraldine S Perry
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more
  35 in total

1.  All-cause mortality in asthma. The importance of age, comorbidity, and socioeconomic status.

Authors:  Nirupama Putcha; Nadia N Hansel
Journal:  Ann Am Thorac Soc       Date:  2014-10

2.  Socioeconomic Characteristics Are Major Contributors to Ethnic Differences in Health Status in Obstructive Lung Disease: An Analysis of the National Health and Nutrition Examination Survey 2007-2010.

Authors:  Carlos H Martinez; David M Mannino; Jeffrey L Curtis; MeiLan K Han; Alejandro A Diaz
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

3.  Differences in Health-Related Quality of Life Between New Mexican Hispanic and Non-Hispanic White Smokers.

Authors:  Alejandro A Diaz; Hans Petersen; Paula Meek; Akshay Sood; Bartolome Celli; Yohannes Tesfaigzi
Journal:  Chest       Date:  2016-06-16       Impact factor: 9.410

Review 4.  Defining COPD-Related Comorbidities, 2004-2014.

Authors:  Carlos H Martinez; David M Mannino; Miguel J Divo
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

5.  Urinary Incontinence in Chronic Obstructive Pulmonary Disease: A Common Co-morbidity or a Typical Adverse Effect?

Authors:  Salvatore Battaglia; Alida Benfante; Stefania Principe; Laura Basile; Nicola Scichilone
Journal:  Drugs Aging       Date:  2019-09       Impact factor: 3.923

6.  Racial-ethnic disparities in self-reported health status among US adults adjusted for sociodemographics and multimorbidities, National Health and Nutrition Examination Survey 2011-2014.

Authors:  Krupa Gandhi; Eunjung Lim; James Davis; John J Chen
Journal:  Ethn Health       Date:  2017-11-02       Impact factor: 2.772

7.  Evaluation of Pregnancy-Associated Plasma Protein-A Levels in Patients with Chronic Obstructive Pulmonary Disease and Associations with Disease Severity.

Authors:  Fahrettin Talay; Mehmet Tosun; Zehra Asuk Yaşar; Özlem Kar Kurt; Aysel Karği; Serkan Öztürk; Mehmet Fatih Özlü; Aytekin Alçelik
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 8.  Patient-centered care for people living with multimorbidity.

Authors:  Cynthia M Boyd; Gregory M Lucas
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

Review 9.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

10.  Associations of Self-Reported Cigarette Smoking with Chronic Obstructive Pulmonary Disease and Co-Morbid Chronic Conditions in the United States.

Authors:  Timothy J Cunningham; Earl S Ford; Italia V Rolle; Anne G Wheaton; Janet B Croft
Journal:  COPD       Date:  2014-09-10       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.